Paraplatin Related Clinical Trials
A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer [Completed]
Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Patients With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy [Recruiting]
Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer [Completed]
Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC [Recruiting]
Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim Followed by Radiotherapy and Paclitaxel/Carboplatin/ZD1839 in Locally Advanced Unresectable Stage IIIA/B Non-Small Cell Carcinoma of the Lung [Completed]
Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer [Active, not recruiting]
Phase II Trial of Gemcitabine and Carboplatin Followed by Paclitaxel and Carboplatin With Radiation for Stage IIIA/IIIB NSCLC. [Active, not recruiting]
First Line Chemotherapy Treatment of Advanced NSCLC [Recruiting]
Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer [Completed]
Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer [Completed]
MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer [Recruiting]
Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse [Recruiting]
Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer [Active, not recruiting]
Evaluation of the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III-IV [Completed]
TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer [Active, not recruiting]
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors [Active, not recruiting]
Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer [Recruiting]
Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Completed]
Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer [Recruiting]
First Line IRESSAâ„¢ Versus Carboplatin/Paclitaxel in Asia [Active, not recruiting]
Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer [Recruiting]
A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer [Active, not recruiting]
A Phase â…¢ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage â…¢ Non-Small-Cell Lung Cancer [Completed]
Combination Trial of Patupilone and Carboplatin in Adult Patients With Advanced Solid Tumors [Recruiting]
Carboplatin and Paclitaxel With or Without Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer [Active, not recruiting]
Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS) [Recruiting]
Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer [Active, not recruiting]
Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin [Recruiting]
A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Patients With Advanced Non-Small Cell Lung Cancer [Not yet recruiting]
Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin [Not yet recruiting]
Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer [Active, not recruiting]
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma [Active, not recruiting]
Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer [Recruiting]
CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL [Recruiting]
Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Active, not recruiting]
Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [Completed]
Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Recruiting]
PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer [Recruiting]
Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed During Surgery [Active, not recruiting]
Phase I Study of TAS-106 in Combo With Carboplatin [Recruiting]
Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer [Recruiting]
Decitabine and Carboplatin in Relapsed Ovarian Cancer [Recruiting]
Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors [Recruiting]
A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer [Recruiting]
Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer [Recruiting]
A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid Tumors [Recruiting]
Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC [Recruiting]
Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer [Recruiting]
Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC) [Recruiting]
Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer [Not yet recruiting]
Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung Cancer [Not yet recruiting]
Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer [Recruiting]
Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates [Recruiting]
A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer [Recruiting]
Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus [Recruiting]
Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma [Recruiting]
Phase II Breast Cancer Treatment Using Weekly Carboplatin+Nab-Paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) [Recruiting]
Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With MPM [Recruiting]
Safety Study of XL147 in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors [Recruiting]
LBH589, Paclitaxel, Carboplatin +/- Bevacizumab for Solid Tumors [Recruiting]
A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC) [Recruiting]
A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer [Recruiting]
Pazopanib Plus Paclitaxel (TAXOL) And Pazopanib Plus Paclitaxel(TAXOL) Plus Carboplatin (PARAPLATIN) [Recruiting]
Study Of SU011248 In Combination With Paclitaxel/Carboplatin In Patients With Advanced Solid Tumors [Recruiting]
Carboplatin, Bevacizumab and Pemetrexed in Advanced Non Small Cell Lung Cancer [Recruiting]
Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Recruiting]
A Dose-Finding Study of E7389 in Combination With Carboplatin in Patients With Solid Tumors [Recruiting]
Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial [Recruiting]
Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology [Recruiting]
A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC [Recruiting]
Carboplatin Plus Docetaxel, Paclitaxel and Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) [Recruiting]
Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer [Not yet recruiting]
Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung Cancer [Recruiting]
A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-Line, Advanced Non-Small Cell Lung Cancer (NSCLC) [Recruiting]
Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer [Recruiting]
Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer [Recruiting]
Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer [Not yet recruiting]
Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma [Recruiting]
Chemoradiation Treatment for Head and Neck Cancer [Recruiting]
Combination Of Lapatinib With Carboplatin, Paclitaxel and Trastuzumab In Metastatic Breast Cancer [Recruiting]
Vinorelbine/Gemcitabine Verses Vinorelbine/Carboplatin in Advanced Non-Small Cell Lung Cancer [Recruiting]
Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients [Recruiting]
Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer [Recruiting]
Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-Naive Patients With Advanced/Metastatic Bladder Carcinoma [Recruiting]
Determination of Carboplatin's Optimal Plasmatic Exposure [Recruiting]
Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery [Recruiting]
Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer [Recruiting]
Ixabepilone in Combination With Carboplatin in Patients With Non-Small Cell Lung Cancer (NSCLC) [Recruiting]
Sorafenib/Carboplatin/Paclitaxel in Patients With Solid Tumors [Recruiting]
Carboplatin Taxol Avastin in Ovarian Cancer (OVCA) [Recruiting]
Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer [Recruiting]
Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-Small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic Therapy [Recruiting]
Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients [Recruiting]
BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC) [Recruiting]
A Study to Assess the Effectiveness of the Combination of Carboplatin, Paclitaxel, Bevacizumab and Combretastatin (CA4P) in Patients With Chemotherapy Naïve Lung Cancer [Recruiting]
Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-Small Cell Lung Cancer [Recruiting]
|
